Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
IPO Year:
Exchange: NYSE
Website: nhireit.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/12/2024 | $67.00 | Market Perform → Outperform | BMO Capital Markets |
2/26/2024 | $55.00 → $63.00 | Equal Weight → Overweight | Wells Fargo |
2/26/2024 | $57.00 → $64.00 | Neutral → Outperform | Wedbush |
1/30/2024 | $69.00 | Buy | Deutsche Bank |
10/3/2023 | $54.00 | Neutral | Wedbush |
9/28/2023 | $54.00 | Hold | Berenberg |
9/20/2023 | $52.00 | Hold | Jefferies |
4/20/2023 | $52.00 | Equal Weight | Wells Fargo |
12/9/2022 | $47.00 → $58.00 | Underperform → Neutral | Credit Suisse |
6/21/2022 | $62.00 | Outperform → Market Perform | BMO Capital Markets |
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
SC 13G/A - NATIONAL HEALTH INVESTORS INC (0000877860) (Subject)
SC 13G/A - NATIONAL HEALTH INVESTORS INC (0000877860) (Subject)
SC 13G/A - NATIONAL HEALTH INVESTORS INC (0000877860) (Subject)
SC 13G/A - NATIONAL HEALTH INVESTORS INC (0000877860) (Subject)
Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Hold and raises the price target from $58 to $65.
In the latest quarter, 4 analysts provided ratings for National Health Investors (NYSE:NHI), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 0 2 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $65.0, a high estimate of $69.00, and a low estimate of $58.00. Observing a 7.14% increase, the current average has
Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Overweight and raises the price target from $63 to $69.
National Health Investors (NYSE:NHI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.06 by 5.66 percent. The company reported quarterly sales of $81.513 million which beat the analyst consensus estimate of $76.851 million by 6.07 percent. This is a 1.06 percent decrease over sales of $82.388 million the same period last year.
National Health Investors (NYSE:NHI) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 1 0 0 Last 30D 0 0 1 0 0 1M Ago 0 2 0 0 0 2M Ago 0 2 0 0 0 3M Ago 1 0 0 0 0 Analysts have recently evaluated National Health Investors and provided 12-month price targets. The average target is $64.5, accompanied by a high estimate of $69.00 and a low estimate of $58.00. Thi
Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Hold and raises the price target from $55 to $58.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy . Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector. PotlatchDeltic Corporation (NASDAQ:PCH) Dividend Yield: 4.07% RBC Capital analyst Matthew McKellar reiterated a Sector Perform rating
Wedbush analyst Richard Anderson maintains National Health Investors (NYSE:NHI) with a Outperform and raises the price target from $64 to $66.
BMO Capital Markets analyst Juan C. Sanabria upgraded National Health Investors, Inc. (NYSE:NHI) from Market Perform to Outperform, maintaining the price forecast of $67. Sanabria sees the potential for multiple expansions for the company, with upside to earnings driven primarily by SHOP and acquisitions. Acquisitions also represent an opportunity with $150 million of debt firepower, given National Health Investors’ low leverage (4.4X net debt/EBITDA). The analyst keeps a more constructive stance on the company’s SHOP portfolio given the recent strong 4Q23 occupancy and a solid start to ’24 despite typical seasonal trends. Sanabria forecasts FY24 SHOP same-store net operating inc
MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today the pricing of an underwritten public offering of 2,400,000 shares of its common stock at a public offering price of $71.25 per share, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters were also granted a 30-day option to purchase up to an additional 360,000 shares of the Company's common stock from the forward purchasers. The offering is expected to close on August 16, 2024, subject to customary closing conditi
MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters of the offering also expect to be granted a 30-day option to purchase up to an additional 300,000 shares of the Company's common stock from the forward purchasers.BofA Securities, J.P. Morgan, Wells Fargo Securities and BMO Capital Markets are acting as joint book-runni
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.90 per common share on November 1, 2024 to stockholders of record as of September 27, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursin
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more informati
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended June 30, 2024 was $0.81 compared to $0.92 during the same period in the prior year. Net income attributable to common stockholders per diluted common share for the six months ended June 30, 2024 was $1.52 compared to $1.71 during the same period in the prior year.National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share for the three months ended June 30, 202
MURFREESBORO, TN / ACCESSWIRE / July 15, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the second quarter ended June 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, August 6, 2024, and will host a conference call on the following day, Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the confirmation number 781474.The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/50711 on Wednesday, August 7, 2024, at 11:00
Believes NHI's Reactive Actions Disclosed in its Supplemental Proxy are Too Little, Too Late, and Fail to Address the Serious Corporate Governance Concerns and Conflicts of Interest Among Board Members Previously Highlighted By Land & Buildings Argues that NHI Should Commit to Working Directly with Shareholders to Identify a New, Truly Independent Director and to Fully Declassifying the Board at the 2025 Annual Meeting Continues to Urge NHI Shareholders to Send a Clear Message that Change is Needed By Voting "AGAINST" Incumbent Directors Robert Webb and Charlotte Swafford Today, Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings"), a significa
MURFREESBORO, TN / ACCESSWIRE / May 7, 2024 / National Health Investors, Inc. (NYSE:NHI) filed a proxy statement supplement (the "Supplement") with the U.S. Securities and Exchange Commission ("SEC") on May 6, 2024, which can be found on the SEC website at www.sec.gov and on the NHI website at https://investors.nhireit.com/filings-and-financials/annual-meeting-materials/default.aspx.The Supplement describes specific steps that the Board of Directors ( the "Board") determined on May 3, 2024, to take in response to stockholders' concerns. These include the following:The Board has committed to submitting to the Company's stockholders at the 2025 annual meeting a proposal to amend the Company's
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more information,
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its second quarter dividend of $0.90 per common share on August 2, 2024 to stockholders of record as of June 28, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilit
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
424B5 - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
424B5 - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
10-Q - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
DEFA14A - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
Believes NHI is Significantly Undervalued with Opportunities to Unlock its Valuable Assets, Including Upcoming Lease Renewal with Tenant National Healthcare Corporation Highlights Poor Corporate Governance and Serious Conflicts of Interest Among Board Members Expresses Serious Concerns that NHI Board Cannot Fairly Represent Both Landlord and Tenant in Lease Renegotiation Given Substantial Economic and Personal Ties to NHC Discloses Likely Substantial Upside to Lease Rental Rates if Lease is Negotiated at Arms-Length Believes Shareholders Need to Send a Clear Message at Upcoming Annual Meeting – Ahead of Critical Lease Renegotiations – that Maintaining the Status Quo is Not an Option
Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that J. Justin Hutchens, Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment Officer, effective immediately. In his expanded role, Hutchens will be responsible for Ventas's capital allocation strategy and execution across the enterprise in addition to his current responsibility for the Company's Senior Housing portfolio. He will oversee both the Senior Housing and Investments teams and continue to report directly to Ventas Chairman and CEO Debra A. Cafaro. "Through his exceptional leadership of our Senior Housing business over the past three years, Justin has proven to be
MURFREESBORO, TN / ACCESSWIRE / May 3, 2022 / National Health Investors, Inc. (NYSE:NHI) announced that Tracy M.J. Colden will join the NHI Board of Directors effective June 1, 2022.Ms. Colden has more than 30 years of experience in the hospitality and lodging industry and is currently General Counsel, Executive Vice President and Corporate Secretary with Playa Hotels & Resorts N. V. (NASDAQ:PLYA), a leading owner, operator and developer of all-inclusive resorts in Mexico and the Caribbean. Ms. Colden served as General Counsel, Executive Vice President and Corporate Secretary at Highland Hospitality Corporation and Crestline Capital Corporation. Prior to joining Crestline Capital, Ms. Colden
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.90 per common share on November 1, 2024 to stockholders of record as of September 27, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursin
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more informati
MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended June 30, 2024 was $0.81 compared to $0.92 during the same period in the prior year. Net income attributable to common stockholders per diluted common share for the six months ended June 30, 2024 was $1.52 compared to $1.71 during the same period in the prior year.National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share for the three months ended June 30, 202
MURFREESBORO, TN / ACCESSWIRE / July 15, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the second quarter ended June 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, August 6, 2024, and will host a conference call on the following day, Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the confirmation number 781474.The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/50711 on Wednesday, August 7, 2024, at 11:00
MURFREESBORO, TN / ACCESSWIRE / May 7, 2024 / National Health Investors, Inc. (NYSE:NHI) filed a proxy statement supplement (the "Supplement") with the U.S. Securities and Exchange Commission ("SEC") on May 6, 2024, which can be found on the SEC website at www.sec.gov and on the NHI website at https://investors.nhireit.com/filings-and-financials/annual-meeting-materials/default.aspx.The Supplement describes specific steps that the Board of Directors ( the "Board") determined on May 3, 2024, to take in response to stockholders' concerns. These include the following:The Board has committed to submitting to the Company's stockholders at the 2025 annual meeting a proposal to amend the Company's
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more information,
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its second quarter dividend of $0.90 per common share on August 2, 2024 to stockholders of record as of June 28, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilit
MURFREESBORO, TN / ACCESSWIRE / May 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year.National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share for the three months ended March 31, 2024 was $1.10 compared to $1.16 during the same period in the prior year.Normalized FFO per diluted common share for the three months ended March 31, 2024 was $1.12 compared to $1.11 during t
MURFREESBORO, TN / ACCESSWIRE / April 12, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2024. NHI plans to issue its earnings release after the market closes on Monday, May 6, 2024, and will host a conference call on the following day, Tuesday, May 7, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the confirmation number 799870.The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/50287 on Tuesday, May 7, 2024, at 11:00 a.m. Eastern
MURFREESBORO, TN / ACCESSWIRE / February 20, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more inform
BMO Capital Markets upgraded National Health from Market Perform to Outperform and set a new price target of $67.00
Wells Fargo upgraded National Health from Equal Weight to Overweight and set a new price target of $63.00 from $55.00 previously
Wedbush upgraded National Health from Neutral to Outperform and set a new price target of $64.00 from $57.00 previously
Deutsche Bank initiated coverage of National Health with a rating of Buy and set a new price target of $69.00
Wedbush initiated coverage of National Health with a rating of Neutral and set a new price target of $54.00
Berenberg initiated coverage of National Health with a rating of Hold and set a new price target of $54.00
Jefferies initiated coverage of National Health with a rating of Hold and set a new price target of $52.00
Wells Fargo initiated coverage of National Health with a rating of Equal Weight and set a new price target of $52.00
Credit Suisse upgraded National Health from Underperform to Neutral and set a new price target of $58.00 from $47.00 previously
BMO Capital Markets downgraded National Health from Outperform to Market Perform and set a new price target of $62.00